Literature DB >> 19414657

Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use.

Samia Mora1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19414657      PMCID： PMC2735461          DOI： 10.1161/CIRCULATIONAHA.108.819359

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  53 in total

Review 1.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

2.  Are measurements of LDL particles ready for prime time?

Authors:  Evan A Stein
Journal:  Clin Chem       Date:  2006-09       Impact factor: 8.327

Review 3.  High-density lipoprotein as a therapeutic target: a systematic review.

Authors:  Inder M Singh; Mehdi H Shishehbor; Benjamin J Ansell
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

4.  We must prevent disease, not predict events.

Authors:  Allan D Sniderman
Journal:  J Am Coll Cardiol       Date:  2008-07-22       Impact factor: 24.094

5.  Low-density lipoprotein size, pravastatin treatment, and coronary events.

Authors:  H Campos; L A Moye; S P Glasser; M J Stampfer; F M Sacks
Journal:  JAMA       Date:  2001-09-26       Impact factor: 56.272

6.  The importance of non-HDL cholesterol reporting in lipid management.

Authors:  Michael J Blaha; Roger S Blumenthal; Eliot A Brinton; Terry A Jacobson
Journal:  J Clin Lipidol       Date:  2008-06-28       Impact factor: 4.766

7.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

8.  LDL particle size in relation to intima-media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia.

Authors:  J Hulthe; O Wiklund; G Bondjers; J Wikstrand
Journal:  J Intern Med       Date:  2000-07       Impact factor: 8.989

9.  Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial.

Authors:  Robert S Rosenson; James D Otvos; David S Freedman
Journal:  Am J Cardiol       Date:  2002-07-15       Impact factor: 2.778

10.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766
View more
  26 in total

Review 1.  Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Anton Stalenhoef
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-10-17       Impact factor: 4.690

2.  Participation of white adipose tissue dysfunction on circulating HDL cholesterol and HDL particle size in apparently healthy humans.

Authors:  Juan G Juárez-Rojas; Ivan Torre-Villalvazo; Aida X Medina-Urrutia; Juan Reyes-Barrera; Víctor H Sainz-Escárrega; Carlos Posadas-Romero; Alejandro Macías-Cruz; Esteban Jorge-Galarza
Journal:  Int J Obes (Lond)       Date:  2019-12-02       Impact factor: 5.095

3.  LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.

Authors:  Rodney G Bowden; Ronald L Wilson; A Alexander Beaujean
Journal:  J Nephrol       Date:  2011 Nov-Dec       Impact factor: 3.902

4.  Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.

Authors:  E Gourgari; M Lodish; R Shamburek; M Keil; R Wesley; M Walter; M Sampson; S Bernstein; D Khurana; C Lyssikatos; S Ten; A Dobs; A T Remaley; C A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-09-15       Impact factor: 5.958

5.  Lipid profiles and coronary artery plaque by CT angiography: Promise for translation of biology to imaging.

Authors:  Connie W Tsao; Christopher J O'Donnell
Journal:  J Cardiovasc Comput Tomogr       Date:  2013-02-27

6.  Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).

Authors:  Mohamed B Elshazly; Renato Quispe; Erin D Michos; Allan D Sniderman; Peter P Toth; Maciej Banach; Krishnaji R Kulkarni; Josef Coresh; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  Circulation       Date:  2015-07-02       Impact factor: 29.690

Review 7.  Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?

Authors:  Michel R Langlois; Børge G Nordestgaard
Journal:  Curr Cardiol Rep       Date:  2018-08-17       Impact factor: 2.931

8.  Reduction in dietary trans fat intake is associated with decreased LDL particle number in a primary prevention population.

Authors:  M Garshick; H Mochari-Greenberger; L Mosca
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-10-05       Impact factor: 4.222

9.  A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study.

Authors:  Norman A Mazer; Franco Giulianini; Nina P Paynter; Paul Jordan; Samia Mora
Journal:  Clin Chem       Date:  2013-02-20       Impact factor: 8.327

Review 10.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.